Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

LUNG stock hub

Pulmonx Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LUNGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

53.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LUNG

In the news

Latest news · LUNG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-86.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-27.5

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LUNG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001127537
Company name	Pulmonx Corporation
Country	United States
Country code	US
Cusip	745848101
Employees	296
Employees Change	5%
Employees Change Percent	1.72
Enterprise value	$47.9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2020-10-01
Isin	US7458481014
Last refreshed	2026-05-10
Market cap	$53.2M
Market cap category	Micro-Cap
Price	$1.26
Price currency	USD
Rev Per Employee	299,138.51x
Sector	Healthcare
Sic	3841
Symbol	LUNG
Website	https://pulmonx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-99.98%
EV Sales Forward	0.51x
EV/Sales	0.54x
FCF yield	-55.26%
P/B ratio	1.16x
P/S ratio	0.6x
PS Forward	0.56x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-58.79%
EBITDA Margin	-57.78%
Gross margin	75.49%
Gross Profit	$66.8M
Gross Profit Growth	4.01%
Gross Profit Growth Q	-1.82%
Gross Profit Growth3 Y	16.44%
Gross Profit Growth5 Y	24.7%
Net Income	$-53.2M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Pretax Margin	-59.37%
Profit Margin	-60.09%
Profit Per Employee	$-179,760
ROA	-24.04
Roa5y	-18.66
ROCE	-51.51
ROE	-86.22
Roe5y	-46.85
ROIC	-27.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-65.79%
Cagr3y	-53.19%
Cagr5y	-50.54%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	1.23x
Revenue Growth Q	-8.66x
Revenue Growth Years	7x
Revenue Growth3 Y	15.54x
Revenue Growth5 Y	21.56x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.65
Assets	$120M
Cash	$61.6M
Current Assets	$92.7M
Current Liabilities	$18.9M
Debt	$56.3M
Debt Equity	$1.23
Equity	$45.8M
Interest Coverage	-15.54
Liabilities	$74.2M
Long Term Assets	$27.2M
Long Term Liabilities	$55.3M
Net Cash	$5.3M
Net Cash By Market Cap	$9.92
Net Cash Growth	-83.37%
Net Debt Equity	$-0.12
Tangible Book Value	$42.7M
Tangible Book Value Per Share	$1.01
WACC	4.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.91
Inventory Turnover	1.31
Net Working Capital	$13.6M
Quick ratio	3.85
Working Capital	$73.8M
Working Capital Turnover	$1.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.39%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-65.76%
200-day SMA	1.72
3Y total return	-89.75%
50-day SMA	1.42
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.04%
All Time High	69.48
All Time High Change	-98.19%
All Time High Date	2020-12-31
All Time Low	1.13
All Time Low Change	11.5%
All Time Low Date	2026-03-30
ATR	0.1
Beta	0.18
Beta1y	2.43
Beta2y	1.23
Ch YTD	-42.99
High	1.3
High52	3.88
High52 Date	2025-07-23
High52ch	-67.53%
Low	1.22
Low52	1.13
Low52 Date	2026-03-30
Low52ch	11.5%
Ma50ch	-11.08%
Premarket Change Percent	0
Premarket Price	$1.27
Price vs 200-day SMA	-26.83%
RSI	43.23
RSI Monthly	33.05
RSI Weekly	40.44
Sharpe ratio	-0.63x
Sortino ratio	-0.82
Total Return	-4.39%
Tr YTD	-42.99
Tr1m	-1.56%
Tr1w	-6.67%
Tr3m	-16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	2
Analyst Price Target Top	$4.58
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.33
Earnings Revenue Estimate	20,361,120x
Earnings Revenue Estimate Growth	-9.66x
Operating Income	$-52.1M
Operating margin	-58.79
Price target	$5.38
Price Target Change	$327
Price Target Change Top	$263

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	37,391,011%
Float Percent	88.53%
Net Borrowing	1,685,000
Shares Insiders	5.16%
Shares Institutions	73.63%
Shares Out	42,237,203
Shares Qo Q	1.19%
Shares Yo Y	4.39%
Short Float	7.53%
Short Ratio	7.04
Short Shares	6.66

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-49.2M
Average Volume	516,771.9x
Bv Per Share	1.08
CAPEX	$-160,000
Ch1m	-1.56
Ch1w	-6.67
Ch1y	-65.76
Ch3m	-16
Ch3y	-89.75
Ch5y	-97.04
Ch6m	-34.37
Change	-0.79%
Change From Open	-0.79
Close	1.27
Days Gap	0
Depreciation Amortization	896,000
Dollar Volume	763,386.1
Earnings Date	2026-04-29
Earnings Time	amc
EBIT	$-52.1M
EBITDA	$-51.2M
EPS	$-1.29
F Score	3
FCF	$-29.4M
FCF EV Yield	-61.35x
FCF Per Share	$-0.7
Financing CF	2,195,000
Fiscal Year End	December
Founded	1,995
Goodwill	2,333,000
Income Tax	$640,000
Investing CF	14,160,000
Ipr	-93.37
Iprfo	-96.85
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	1.69
Ma150ch	-25.49%
Ma20	1.33
Ma20ch	-5.48%
Net CF	-12,983,000
Next Earnings Date	2026-07-29
Open	1.27
Optionable	Yes
Position In Range	49.38
Post Close	1.26
Postmarket Change Percent	2.38
Postmarket Price	$1.29
Ppne	19,714,000
Pre Close	1.27
Price Date	2026-05-08
Ptbv Ratio	1.25
Relative Volume	1.18x
Revenue	88,545,000x
SBC By Revenue	22.31x
Share Based Comp	19,757,000
Tax By Revenue	0.72x
Tr6m	-34.37%
Us State	California
Volume	605,862
Z Score	-5.42

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LUNG pay a dividend?

Capital-return profile for this ticker.

Performance

LUNG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LUNG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+73.6%

Float: +88.5% of shares outstanding

Insider ownership

+5.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LUNG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.2

Neutral momentum band

Price vs 200-day MA

-26.8%

50/200-day relationship not available

Beta (5Y)

0.18

Less volatile than the market

Sharpe ratio

-0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LUNG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LUNG stock rating?

Pulmonx Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LUNG analysis?

The full report lives at /stocks/LUNG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LUNG?

The latest report frames LUNG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LUNG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.